688212 澳华内镜
已收盘 02-10 15:00:01
资讯
新帖
简况
2月2日澳华内镜跌5.34%，富国精准医疗混合A基金重仓该股
证券之星 · 02-02
2月2日澳华内镜跌5.34%，富国精准医疗混合A基金重仓该股
股市必读：澳华内镜（688212）预计2025年全年营业收入7.64亿元至7.74亿元
证券之星 · 01-30
股市必读：澳华内镜（688212）预计2025年全年营业收入7.64亿元至7.74亿元
澳华内镜(688212.SH)发预减，预计2025年度归母净利润同比下降44.89%到61.69%
智通财经 · 01-29
澳华内镜(688212.SH)发预减，预计2025年度归母净利润同比下降44.89%到61.69%
1月28日澳华内镜创60日新低，富国精准医疗混合A基金重仓该股
中金财经 · 01-28
1月28日澳华内镜创60日新低，富国精准医疗混合A基金重仓该股
澳华内镜：1月7日高管顾小舟减持股份合计62.67万股
证券之星 · 01-08
澳华内镜：1月7日高管顾小舟减持股份合计62.67万股
1月7日澳华内镜现1笔大宗交易 机构净买入2679.77万元
证券之星 · 01-07
1月7日澳华内镜现1笔大宗交易 机构净买入2679.77万元
股市必读：1月5日澳华内镜现1笔大宗交易 机构净买入2621.49万元
证券之星 · 01-06
股市必读：1月5日澳华内镜现1笔大宗交易 机构净买入2621.49万元
澳华内镜：12月19日高管顾小舟减持股份合计5628股
证券之星 · 2025-12-23
澳华内镜：12月19日高管顾小舟减持股份合计5628股
澳华内镜：12月16日高管顾小舟减持股份合计5.91万股
证券之星 · 2025-12-18
澳华内镜：12月16日高管顾小舟减持股份合计5.91万股
澳华内镜：12月11日高管顾小舟减持股份合计20万股
证券之星 · 2025-12-12
澳华内镜：12月11日高管顾小舟减持股份合计20万股
澳华内镜：12月8日高管顾小舟减持股份合计20万股
证券之星 · 2025-12-09
澳华内镜：12月8日高管顾小舟减持股份合计20万股
澳华内镜：12月3日高管顾小舟减持股份合计10万股
中金财经 · 2025-12-04
澳华内镜：12月3日高管顾小舟减持股份合计10万股
澳华内镜：12月2日高管顾小舟减持股份合计20万股
证券之星 · 2025-12-03
澳华内镜：12月2日高管顾小舟减持股份合计20万股
澳华内镜：12月1日高管顾小舟减持股份合计20万股
证券之星 · 2025-12-02
澳华内镜：12月1日高管顾小舟减持股份合计20万股
澳华内镜：11月24日高管顾小舟减持股份合计17.03万股
证券之星 · 2025-11-25
澳华内镜：11月24日高管顾小舟减持股份合计17.03万股
【机构调研记录】汇添富基金调研冰轮环境、澳华内镜等5只个股（附名单）
证券之星 · 2025-11-17
【机构调研记录】汇添富基金调研冰轮环境、澳华内镜等5只个股（附名单）
【机构调研记录】上银基金调研澳华内镜、金达威
证券之星 · 2025-11-17
【机构调研记录】上银基金调研澳华内镜、金达威
澳华内镜：11月13日接受机构调研，富国基金、中信资管等多家机构参与
证券之星 · 2025-11-14
澳华内镜：11月13日接受机构调研，富国基金、中信资管等多家机构参与
11月10日澳华内镜涨5.75%，富国精准医疗混合A基金重仓该股
证券之星 · 2025-11-10
11月10日澳华内镜涨5.75%，富国精准医疗混合A基金重仓该股
澳华内镜涨5.75%，华安证券一个月前给出“买入”评级
证券之星 · 2025-11-10
澳华内镜涨5.75%，华安证券一个月前给出“买入”评级
加载更多
公司概况
公司名称：
上海澳华内镜股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-11-15
主营业务：
上海澳华内镜股份有限公司的主营业务是电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。公司的主要产品是内窥镜设备、内窥镜诊疗耗材、内窥镜维修服务。
发行价格：
22.50
{"stockData":{"symbol":"688212","market":"SH","secType":"STK","nameCN":"澳华内镜","latestPrice":42.75,"timestamp":1770706801000,"preClose":42.75,"halted":0,"volume":1417463,"delay":0,"changeRate":0,"floatShares":135000000,"shares":135000000,"eps":-0.5376,"marketStatus":"已收盘","change":0,"latestTime":"02-10 15:00:01","open":42.83,"high":43.53,"low":42.6,"amount":60989400,"amplitude":0.0218,"askPrice":42.76,"askSize":55,"bidPrice":42.75,"bidSize":11,"shortable":0,"etf":0,"ttmEps":-0.5376,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":5,"adr":0,"adjPreClose":42.75,"symbolType":"stock_kcb","openAndCloseTimeList":[[1770687000000,1770694200000],[1770699600000,1770706800000]],"highLimit":47.03,"lowLimit":38.48,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":134665250,"isCdr":false,"pbRate":4.62,"roa":"--","roe":"--","epsLYR":0.16,"committee":0.034483,"marketValue":5757000000,"turnoverRate":0.0105,"status":2,"afterMarket":{"amount":0,"volume":0,"close":42.75,"buyVolume":0,"sellVolume":0,"time":1770708837558,"indexStatus":"已收盘 02-10 15:30:00","preClose":42.75},"floatMarketCap":5757000000},"requestUrl":"/m/hq/s/688212","defaultTab":"news","newsList":[{"id":"2608350851","title":"2月2日澳华内镜跌5.34%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608350851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608350851?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:42","pubTimestamp":1770021744,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日澳华内镜跌5.34%，收盘报43.8元，换手率2.85%，成交量3.84万手，成交额1.71亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共20家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.77亿元，最新净值2.987，较上一交易日上涨0.91%，近一年上涨35.18%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2607058683","title":"股市必读：澳华内镜（688212）预计2025年全年营业收入7.64亿元至7.74亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607058683","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607058683?lang=zh_cn&edition=full","pubTime":"2026-01-30 02:38","pubTimestamp":1769711890,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，澳华内镜报收于42.15元，下跌0.31%，换手率1.14%，成交量1.54万手，成交额6497.65万元。业绩披露要点业绩预告澳华内镜发布业绩预告，预计2025年全年营业收入7.64亿元至7.74亿元。公司公告汇总2025年年度业绩预告上海澳华内镜股份有限公司预计2025年度实现营业收入76,431万元到77,439万元，同比增长1.97%到3.31%；归属于母公司所有者的净利润为805万元到1,158万元，同比下降44.89%到61.69%；扣除非经常性损益后的净利润为-1,053万元到-700万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000001515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212"],"gpt_icon":0},{"id":"2607924081","title":"澳华内镜(688212.SH)发预减，预计2025年度归母净利润同比下降44.89%到61.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607924081","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607924081?lang=zh_cn&edition=full","pubTime":"2026-01-29 19:59","pubTimestamp":1769687988,"startTime":"0","endTime":"0","summary":"智通财经APP讯，澳华内镜(688212.SH)发布公告，公司预计2025年度实现归属于母公司所有者的净利润为805万元到1158万元，与上年同期相比，将减少943.22万元到1,296.22万元，同比下降44.89%到61.69%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"澳华内镜(688212.SH)发预减，预计2025年度归母净利润同比下降44.89%到61.69%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688212"],"gpt_icon":0},{"id":"2606796036","title":"1月28日澳华内镜创60日新低，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606796036","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606796036?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:49","pubTimestamp":1769590150,"startTime":"0","endTime":"0","summary":"证券之星消息，1月28日澳华内镜创60日新低，收盘报42.28元，当日跌4.73%，换手率1.77%，成交量2.38万手，成交额1.02亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共20家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.77亿元，最新净值3.0291，较上一交易日上涨0.11%，近一年上涨37.08%。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/28/20260128195308.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/28/20260128195308.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260128/31979476.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2601366796","title":"澳华内镜：1月7日高管顾小舟减持股份合计62.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366796","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601366796?lang=zh_cn&edition=full","pubTime":"2026-01-08 20:02","pubTimestamp":1767873756,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月8日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2026年1月7日公司董事顾小舟共减持公司股份62.67万股，占公司总股本为0.4654%。变动期间公司股价上涨2.18%，1月7日当日收盘报46.48元。该股最近90天内共有11家机构给出评级，买入评级7家，增持评级4家；过去90天内机构目标均价为61.36。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800035155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2601879501","title":"1月7日澳华内镜现1笔大宗交易 机构净买入2679.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601879501","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601879501?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:39","pubTimestamp":1767778792,"startTime":"0","endTime":"0","summary":"证券之星消息，1月7日澳华内镜发生大宗交易，交易数据如下：大宗交易成交价格42.76元，相对当日收盘价折价8%，成交62.67万股，成交金额2679.77万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海浦东新区联洋证券营业部。近三个月该股共发生2笔大宗交易，合计成交1.25万手，折价成交2笔。截至2026年1月7日收盘，澳华内镜报收于46.48元，上涨2.18%，换手率1.98%，成交量2.67万手，成交额1.23亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700027558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2601834993","title":"股市必读：1月5日澳华内镜现1笔大宗交易 机构净买入2621.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601834993","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601834993?lang=zh_cn&edition=full","pubTime":"2026-01-06 03:54","pubTimestamp":1767642850,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，澳华内镜报收于45.47元，上涨4.03%，换手率1.71%，成交量2.3万手，成交额1.04亿元。当日关注点来自交易信息汇总：1月5日主力资金净流入483.74万元，显示主力对澳华内镜的积极介入。来自交易信息汇总：当日发生1笔大宗交易，机构净买入2621.49万元，反映机构投资者的显著增持行为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600002935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2593920524","title":"澳华内镜：12月19日高管顾小舟减持股份合计5628股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593920524","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593920524?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:02","pubTimestamp":1766491343,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月23日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年12月19日公司董事顾小舟共减持公司股份5628.0股，占公司总股本为0.0042%。变动期间公司股价下跌0.19%，12月19日当日收盘报46.76元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300035424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2592080829","title":"澳华内镜：12月16日高管顾小舟减持股份合计5.91万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592080829","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592080829?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:02","pubTimestamp":1766059350,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月18日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年12月16日公司董事顾小舟共减持公司股份5.91万股，占公司总股本为0.0439%。变动期间公司股价下跌0.47%，12月16日当日收盘报46.5元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800033607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2590945505","title":"澳华内镜：12月11日高管顾小舟减持股份合计20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590945505","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590945505?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:02","pubTimestamp":1765540934,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月12日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年12月11日公司董事顾小舟共减持公司股份20.0万股，占公司总股本为0.1485%。变动期间公司股价上涨1.34%，12月11日当日收盘报47.63元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200035701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2590437693","title":"澳华内镜：12月8日高管顾小舟减持股份合计20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590437693","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590437693?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:02","pubTimestamp":1765281746,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月9日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年12月8日公司董事顾小舟共减持公司股份20.0万股，占公司总股本为0.1485%。变动期间公司股价下跌1.32%，12月8日当日收盘报47.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900035064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2588813078","title":"澳华内镜：12月3日高管顾小舟减持股份合计10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588813078","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588813078?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:17","pubTimestamp":1764850647,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月4日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年12月3日公司董事顾小舟共减持公司股份10.0万股，占公司总股本为0.0743%。变动期间公司股价下跌0.02%，12月3日当日收盘报46.82元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/04/20251204180995.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/04/20251204180995.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251204/31845221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2588458210","title":"澳华内镜：12月2日高管顾小舟减持股份合计20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588458210","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588458210?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:03","pubTimestamp":1764763390,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月3日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年12月2日公司董事顾小舟共减持公司股份20.0万股，占公司总股本为0.1485%。变动期间公司股价下跌1.18%，12月2日当日收盘报46.83元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300034919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2588030194","title":"澳华内镜：12月1日高管顾小舟减持股份合计20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588030194","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588030194?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:02","pubTimestamp":1764676958,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月2日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年12月1日公司董事顾小舟共减持公司股份20.0万股，占公司总股本为0.1485%。变动期间公司股价上涨0.23%，12月1日当日收盘报47.39元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200034512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2586742058","title":"澳华内镜：11月24日高管顾小舟减持股份合计17.03万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586742058","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586742058?lang=zh_cn&edition=full","pubTime":"2025-11-25 20:02","pubTimestamp":1764072171,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月25日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年11月24日公司董事顾小舟共减持公司股份17.03万股，占公司总股本为0.1265%。变动期间公司股价下跌0.45%，11月24日当日收盘报46.48元。该股最近90天内共有14家机构给出评级，买入评级9家，增持评级5家；过去90天内机构目标均价为62.36。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500034269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2584057691","title":"【机构调研记录】汇添富基金调研冰轮环境、澳华内镜等5只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2584057691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584057691?lang=zh_cn&edition=full","pubTime":"2025-11-17 08:02","pubTimestamp":1763337733,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月14日披露的机构调研信息，汇添富基金近期对5家上市公司进行了调研，相关名单如下：1）冰轮环境 调研纪要：公司第三季度营收17.2亿元，同比增长6.88%，归母净利润1.6亿元，同比增长13.54%。前三季度营收48.3亿元，同比下降2.45%；归母净利润4.28亿元，同比下降9.68%。公司拥有有效专利566件，差别化纤维产量占比达27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700001946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0259","BK0188","688212","BK0117","000811","BK0151","BK0175","BK0251"],"gpt_icon":0},{"id":"2584691787","title":"【机构调研记录】上银基金调研澳华内镜、金达威","url":"https://stock-news.laohu8.com/highlight/detail?id=2584691787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584691787?lang=zh_cn&edition=full","pubTime":"2025-11-17 08:01","pubTimestamp":1763337666,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月14日披露的机构调研信息，上银基金近期对2家上市公司进行了调研，相关名单如下：1）澳华内镜 调研纪要：Q-400 3D超高清软镜系统在成像技术、操控性和多功能集成方面实现升级，具备3D成像、EDOF、高光谱染色和STCE图像强化功能。上银基金成立于2013年，截至目前，资产管理规模2515.29亿元，排名33/211；资产管理规模1688.89亿元，排名31/211；管理公募基金数106只，排名72/211；旗下公募基金经理21人，排名67/211。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700001878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002626","BK0191","BK0251","BK0226","BK0197","688212"],"gpt_icon":0},{"id":"2583571611","title":"澳华内镜：11月13日接受机构调研，富国基金、中信资管等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2583571611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583571611?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:37","pubTimestamp":1763113024,"startTime":"0","endTime":"0","summary":"答：截至2025年6月30日，公司内窥镜机器人系统已累计投入研发费用6721.4万元。目前，内窥镜机器人系统已完成型检，并准备注册临床入组工作。澳华内镜主营业务：电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。该股最近90天内共有15家机构给出评级，买入评级9家，增持评级6家；过去90天内机构目标均价为62.36。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2582087823","title":"11月10日澳华内镜涨5.75%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582087823","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582087823?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:29","pubTimestamp":1762763354,"startTime":"0","endTime":"0","summary":"证券之星消息，11月10日澳华内镜涨5.75%，收盘报50.97元，换手率3.95%，成交量5.32万手，成交额2.7亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共19家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为34.91亿元，最新净值3.2188，较上一交易日下跌1.61%，近一年上涨33.21%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2582823038","title":"澳华内镜涨5.75%，华安证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2582823038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582823038?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:29","pubTimestamp":1762763345,"startTime":"0","endTime":"0","summary":"今日澳华内镜涨5.75%，收盘报50.97元。2025年9月29日，华安证券研究员谭国超,李婵发布了对澳华内镜的研报《上半年业务持续承压，预计下半年修复》，该研报对澳华内镜给出“买入”评级。2025-2027年对应的EPS分别约0.29元、0.69元和1.02元，对应的PE估值分别为165倍、70倍和47倍，维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为14.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","600909"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770720249969,"stockEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.1131},{"period":"3month","weight":-0.1684},{"period":"6month","weight":-0.1978},{"period":"1year","weight":0.0523},{"period":"ytd","weight":-0.022}],"compareEarnings":[{"period":"1week","weight":0.0267},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0301},{"period":"6month","weight":0.1194},{"period":"1year","weight":0.248},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海澳华内镜股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"5549人(较上一季度增加41.52%)","perCapita":"24268股","listingDate":"2021-11-15","address":"上海市闵行区光中路133弄66号","registeredCapital":"13466万元","survey":" 上海澳华内镜股份有限公司的主营业务是电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。公司的主要产品是内窥镜设备、内窥镜诊疗耗材、内窥镜维修服务。","listedPrice":22.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"澳华内镜(688212)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供澳华内镜(688212)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"澳华内镜,688212,澳华内镜股票,澳华内镜股票老虎,澳华内镜股票老虎国际,澳华内镜行情,澳华内镜股票行情,澳华内镜股价,澳华内镜股市,澳华内镜股票价格,澳华内镜股票交易,澳华内镜股票购买,澳华内镜股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"澳华内镜(688212)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供澳华内镜(688212)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}